Assenagon Asset Management S.A. Has $10.81 Million Position in CorVel Corp. $CRVL

Assenagon Asset Management S.A. grew its holdings in shares of CorVel Corp. (NASDAQ:CRVL) by 14.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 197,858 shares of the business services provider’s stock after purchasing an additional 25,366 shares during the quarter. Assenagon Asset Management S.A. owned about 0.39% of CorVel worth $10,813,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently bought and sold shares of CRVL. Northwestern Mutual Wealth Management Co. acquired a new position in CorVel during the 3rd quarter worth $31,000. Los Angeles Capital Management LLC bought a new position in shares of CorVel in the fourth quarter worth about $33,000. Quarry LP lifted its position in shares of CorVel by 218.6% during the 3rd quarter. Quarry LP now owns 513 shares of the business services provider’s stock worth $40,000 after purchasing an additional 352 shares during the last quarter. Eagle Bay Advisors LLC acquired a new position in shares of CorVel during the 4th quarter worth about $37,000. Finally, Rockefeller Capital Management L.P. boosted its stake in CorVel by 66.9% during the 4th quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock valued at $39,000 after purchasing an additional 230 shares during the period. 51.36% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, VP Jennifer Yoss sold 1,999 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $61.02, for a total value of $121,978.98. Following the sale, the vice president owned 2,173 shares of the company’s stock, valued at $132,596.46. The trade was a 47.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jeffrey J. Michael sold 9,000 shares of the stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $60.98, for a total transaction of $548,820.00. Following the transaction, the director owned 559,721 shares of the company’s stock, valued at approximately $34,131,786.58. This represents a 1.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 13,249 shares of company stock worth $807,126. Company insiders own 44.56% of the company’s stock.

CorVel Trading Up 2.0%

CorVel stock opened at $62.99 on Friday. The company has a market cap of $3.19 billion, a PE ratio of 29.43 and a beta of 0.99. CorVel Corp. has a 1 year low of $44.83 and a 1 year high of $105.50. The company’s 50-day moving average is $59.07 and its two-hundred day moving average is $59.39.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings results on Tuesday, May 19th. The business services provider reported $0.61 earnings per share (EPS) for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.51%.The business had revenue of $248.55 million for the quarter.

Wall Street Analyst Weigh In

Several analysts have issued reports on CRVL shares. Weiss Ratings lowered shares of CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, April 6th. Wall Street Zen raised shares of CorVel from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).